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T Cell Receptor–MHC Minireview
Interactions up Close
I MHC molecules the peptide, usually derived from pro-
teins in the cytoplasm of any cell, is generated by the
proteasome, transported into the endoplasmic reticu-
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lum, loaded onto MHC molecules, and presented on theHoward Hughes Medical Institute
cell surface to the surveillance system of circulatingCambridge, Massachusetts 02138
CTL. TCR recognition of such peptide/MHCI complexes
usually triggers a cytotoxic response killing the virally
infected or otherwise abnormal cell. On class II MHC
In the last four years, the atomic structures of more than molecules the peptide, usually derived from extracellular
a half-dozen of the intercellular recognition complexes, antigens, is generated by endosomal proteolysis of pro-
formed by abT cell receptors (abTCR) on cytotoxic T teins after they are endocytosed by specialized antigen
lymphocytes (CTL) or T helper cells and MHC/peptide presenting cells such as dendrocytes or B cells. TCR
complexes on antigen presenting cells, have been visu- recognition of such peptide/MHCII complexes usually
alized by X-ray crystallography (Figure 1A). These mo- triggers the release of cytokines that regulate inflamma-
lecular complexes are the common recognition compo- tion and the response of other cells, such as signaling
nent in a diverse set of cell–cell encounters that activate for the secretion of antibodies.
the T cell receptor both during development of the reper- Although both self- and non-self-peptides are presented
toire of T cells within an individual organism (positive on MHC molecules, many mechanisms, collectively called
selection; negative selection; peripheral survival) and immune tolerance, exist to avoid TCR reactions with self-
during the control (T helper) and effector stages (T killer) peptide/MHC complexes. These mechanisms involve, for
of an immune response. In the adaptive immune re- example, the regulation of when and how much peptide
sponse, antigens are recognized by hypervariable mole- is presented, the elimination or control of self-reactive T
cules, antibodies or T cell receptors, which are ex- cells, the upregulation by inflammation of costimulatory
pressed with sufficiently diverse structures to be able molecules on antigen-presenting cells that can provide
to recognize any protein antigen. Antibodies can bind a second signal, and generally the requirement for more
to any part of the surface of a protein antigen. The than just a good fit between TCR and a peptide/MHC
receptors on T cells, however, are restricted to sensing complex to initiate T cell activation. Occasionally break-
the presence of protein antigens by binding to short downs in immune tolerance result in autoimmune dis-
peptides from the antigens that are presented on the orders.
surface of other cells bound to class I or class II mole- TCRs Bind Very Similarly
cules of the major histocompatibility complex (MHC). to Peptide/MHC Complexes
The crystallographic studies of TCR/peptide/MHC com- The X-ray structures of both human and murine abTCR/
plexes have shown examples of viral antigen recogni- peptide/MHC complexes from different TCR bound to
tion, agonist and antagonist ligand recognition, and the both MHCI/peptide and MHCII/peptide complexes show
allorecognition of graft rejection. Some induced fitting a similar binding mode. The CDR2 loops of a and b contact
at the TCR interface is observed upon peptide/MHC only the MHC molecules, while the CDR1 and CDR3 loops
binding, but no global conformational change has been contact both peptide and MHC atoms (Figure 1B). Fur-
observed that could initiate a signal or determine the thermore, the Va domain is always closer to the N-termi-
different signals associated with agonist and antagonist nal end of the bound peptide (left in Figures 1A–1C) and
ligands. All TCRs studied have been found to bind to the Vb domain to the C-terminal end, with the TCR taking
peptide/MHC complexes in a similar way, positioned an angled path across the MHC binding site. In 4 TCR/
across the MHC/peptide surface at an angle between peptide/MHCI complexes, the angle between the pep-
tide direction and the long axis of the abTCR interface458 and 808 (Figure 1B). This similarity in binding mode is
is between 458 and 708, while the two TCR/peptide/apparently achieved without using conserved contacts
MHCII structures are at one end of the range, 708 andwhich may suggest its importance for initiating signals
808 (Figure 1C). Because the CDR3 loops are the mostwithin T cells.
variable, being encoded by D and J gene segments, itThe T cell receptor is composed of two membrane
was anticipated that they would contact the most di-anchored polypeptides, a and b (red and blue in Figure
verse part of the peptide/MHC complex, the peptide.1A), that each contain one constant (C) and one variable
There are only about 50 TCR Va and 50 Vb genes, which(V) domain. The V domain is encoded by assembled
encode the CDR1 and CDR2 loops in the germline.segments of genes, similar to antibodies. The comple-
The surface of the TCR that contacts peptide/MHC ismentarity determining regions (CDRs) are the hypervari-
relatively flat, sometimes with a central cavity. The MHCable loops at one end of the TCR (red and blue in Figure
surface by contrast contains two high peaks (symbol-1B) that recognize the composite antigenic surface
ized by large zigzag in Figure 2C). To achieve a largemade from the jaws of an MHC molecule (gray in Figure
interface (1500 to 2200 A˚2 of buried solvent-accessible1B) and a bound peptide (yellow in Figure 1B). On class
surface area), the TCR apparently binds between these
two highpoints on the MHC/peptide surface as pre-
dicted from mutagenesis experiments (reviewed inE-mail: hennecke@crystal.harvard.edu (J. H.), dcwadmin@crystal.
harvard.edu (D. C. W.) Bjorkman, 1997). The TCR footprints on the MHC/peptide
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Figure 1. TCR/Peptide/MHC Complexes
(A) Overall view between cells (Garcia et al., 1998). (B) CDR placement over the peptide/MHC surface (Reinherz et al., 1999). (C) Range of
TCR binding modes in TCR/peptide/MHC complexes. Short lines by the TCR labels indicate the angles at which each TCR binds across the
peptide/MHC surface. (TCR counterclockwise: Garcia et al., 1998; Teng et al., 1998; Ding et al., 1998; Garboczi et al., 1996; Hennecke et al.,
2000; Reinherz et al., 1999).
vary considerably with the ratio of the surface buried by contacts are not conserved? Because there are many
conserved MHC residues and about 50 Va and Vb genes,Va and Vb domains ranging from 2:1 to 1:2. However, the
location and size of the CDR1, 2, and 3 footprints of Va the binding mode might have been preserved by a com-
binatorial mechanism where different TCRs contact avary much less than the footprints of Vb, giving the impres-
sion that different TCRs pivot about contacts made by the different subset of MHC residues, but even TCRs with
identical CDR1 and CDR2 loops in one V domain canCDR1 and CDR2 of Va (lower left in Figure 1C).
Of the 31 MHC amino acid positions contacted in at interact very differently with MHC molecules, as illus-
trated by the different binding of 2C TCR to H-2Kb/DEV8least one of the known TCR/peptide/MHC structures,
only a subset of about 1/2 of those are actually con- and D10 TCR to I-Ak/CA (references in Figure 1). An
alternative is that the coevolution of TCRs with MHCtacted in each complex. Even contacts to the same
peptide/MHC complex by two different TCRs can share molecules in a species has only selected for TCRs that
can initiate a signal (e.g., during positive selection). Anyas few as one conserved atomic interaction (Garboczi
et al., 1996; Ding et al., 1998). Which of these residues binding mode consistent with signaling would have been
preserved, irrespective of the conservation of particularare contacted depends on global parameters like the
twist, tilt, and shift of the TCR over the pMHC surface atomic contacts.
The existence of an approximately conserved TCR(Teng et al., 1998), the different angles found between
the Va and Vb domains, and the conformation and length orientation might be important for the recognition of the
TCR/peptide/MHC complex by coreceptor moleculesof the CDR loops. At present, there is no simple code
for predicting these global parameters or the details of on the T cell surface like CD4 or CD8 or to facilitate a
proposed association of TCR/peptide/MHC complexesbinding from the sequence of a TCR and the peptide/
MHC antigen, although one contact is conserved in the into oligomers to initiate signaling within the T cell.
Recognizing Foreign Antigenstwo complexes with class II MHC molecules (Reinherz
et al., 1999; Hennecke et al., 2000). Only one-third of the surface of peptides bound to MHC
molecules is unoccluded and available to be recognizedThe lack of conserved contacts between all TCRs and
the conserved residues on the MHC molecules presents by contacts to a TCR. TCRs contact from 5 to 7 of a
span of 8 residues of MHCI bound peptides (8-mers andan apparent paradox. How do TCRs bind similarly if
Minireview
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Figure 2. TCR–Peptide/MHC Interfaces
(A) A TCR with flat (green) surface contacting projecting peptide (yellow) sidechains (Hennecke et al., 2000). (B) A TCR with a deep pocket
between CDR3 loops (green) engulfing a peptide tyrosine sidechain (yellow) (Garboczi et al., 1996). (C) The A6-TCR bound to an agonist Tax
peptide (red TCR) and an antagonist, singly substituted (P6A) peptide (blue TCR) have almost identical bound conformations but initiate very
different signals (Ding et al., 1999). (D) An allo-complex, between a TCR and a mismatched MHC molecule, has an unusual CDR3a conformation
(green arrow) extending away from the peptide but initiates a strong agonist signal (Reiser et al., 2000).
9-mers) and from 6 to 7 of a span of 9 residues of MHCII ligands do not activate T cells, instead they bind TCR,
cause some hypophosphorylation, and inhibit T cell re-bound peptides (13-mers and 16-mers). In some cases
a relatively flat surface of a TCR (green in Figure 2A) sponses by agonist ligands.) Such peptides are called
altered-peptide-ligands (APL) (reviewed in Sloan-Lan-contacts the projecting sidechains from a bound peptide
(yellow in Figure 2A). In other cases the central peptide caster and Allen, 1996). One structural study of three
TCR/APL/MHC complexes showed that some peptideresidue (yellow tyrosine in Figure 2B) is completely sur-
rounded by a deep pocket in the TCR surface formed substitutions could be accommodated by very minor
readjustments in the TCR/peptide interface (induced fit),primarily by the two CDR3 loops (green in Figure 2B).
The interfaces sometimes contain water molecules and which did not propagate to the outer surface of the TCR
(Ding et al., 1999). Furthermore there was no correlationby one measure of complementarity they score below
interfaces within oligomeric proteins but near the range between the minor structural refitting and the signaling
outcome. Very minor refitting resulted in an antagonistof Fab/antigen complexes (Garcia et al., 1999).
The number of contacts between TCR and peptide is (compare red and blue TCR conformations in Figure 2C
with a peptide Pro-6 to Ala substitution.), whereas onlimited, suggesting that crossreactivity in which more
than one peptide sequence can fit between a given TCR/ another APL a more extensive refitting diminished sig-
naling only to a weak agonist (producing full activationMHC pair will occur, as has been observed in functional
experiments. Although in crossreactions different pep- but at much higher peptide concentration). A compari-
son of the structures of a weak and a strong agonisttides can generate the same activation signal, in other
cases TCR signaling can be exquisitely sensitive to pep- peptide also showed only minor adjustments in the TCR/
peptide/MHC interface (Degano et al., 2000). This lacktide sequence. Single amino acid substitutions in pep-
tides, even in residues not directly contacted by the of correlation between the structure and the signal gen-
erated is consistent with suggestions that tightness orTCR, can convert a strong agonist peptide/MHC ligand
into a weak agonist or even an antagonist. (Antagonist duration of TCR binding causes different signals (Davis
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et al., 1998), not different conformations of the TCR/ tal studied to date. The possibility, for example, that the
peptide/MHC complex. cell surface TCR contains two abTCR units (Fernandez-
Induced Fit in TCR/Ligand Binding, but No Global Miguel et al., 1999) suggests that until the full TCR with
Conformational Changes CD3 and zeta chains is assembled and crystallized,
The structure of a murine TCR has been determined choosing among signal initiation mechanisms involving
both unliganded and bound to a peptide/MHC complex oligomerization or allosteric switches will be difficult.
(reviewed in Garcia et al., 1999). A comparison indicates
Selected Readingsinduced fitting of the TCR CDR loops to accommodate
the ligand with differences in structure ranging from 4 to
Bjorkman, P.J. (1997). Cell 89, 167–170.
6 A˚. These conformational differences do not appear to
Davis, M.M., Boniface, J.J., Reich, Z., Lyons, D., Hampl, J., Arden,propagate away from the TCR/peptide/MHC interface
B., and Chien, Y.H. (1998). Annu. Rev. Immunol. 16, 523–544.
to the outer surface of the TCR. Because the induced
Degano, M., Garcia, K.C., Apostolopoulos, V., Rudolph, M.G., Tey-
fit is only local, no conformational change of the TCR ton, L., and Wilson, I.A. (2000). Immunity 12, 251–261.
that might signal to the cytoplasm that a ligand has been
Ding, Y.H., Smith, K.J., Garboczi, D.N., Utz, U., Biddison, W.E., and
engaged has been discovered. This again suggests sig- Wiley, D.C. (1998). Immunity 8, 403–411.
naling models based on the affinity or the kinetic lifetime Ding, Y.H., Baker, B.M., Garboczi, D.N., Biddison, W.E., and Wiley,
of the complex. D.C. (1999). Immunity 11, 45–56.
Graft Rejection—Alloreactivity Fernandez-Miguel, G., Alarcon, B., Iglesias, A., Bluethmann, H., Al-
The immune reaction to the introduction of cells ex- varez-Mon, M., Sanz, E., and de la Hera, A. (1999). Proc. Natl. Acad.
Sci. USA 96, 1547–1552.pressing a foreign MHC molecule into an MHC mis-
matched host, an alloreaction (allos, Greek for other), Garboczi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., and
Wiley, D.C. (1996). Nature 384, 134–141.is particularly severe. Up to 10% of peripheral T cells
Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson,respond to such an allo-challenge, while less than 1%
M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). Sciencerespond to a typical viral challenge (reviewed in Kranz,
274, 209–219.2000). Two models have been proposed to account for
Garcia, K.C., Degano, M., Pease, L.R., Huang, M., Peterson, P.A.,the high reactivity. In one, the TCR might bind to the
Teyton, L., and Wilson, I.A. (1998). Science 279, 1166–1172.allo-MHC/peptide complex primarily to the polymorphic
Garcia, K.C., Teyton, L., and Wilson, I.A. (1999). Annu. Rev. Immunol.and conserved MHC residues of the allo-MHC molecule.
17, 369–397.Alternatively, because the allo-MHC can bind a new
Hennecke, J., Carfi, A., and Wiley, D.C. (2000). EMBO J. 19, 5611–constellation of self-peptides, many peptide/MHC li-
5624.
gands would be generated for which T cells would not
Kranz, D.M. (2000). Nat. Immunol. 1, 277–278.have been eliminated by tolerance mechanisms like neg-
Pecorari, F., Tissot, A.C., and Pluckthun, A. (1999). J. Mol. Biol. 285,ative selection. The X-ray structure of a murine TCR
1831–1843.
bound to an allo-MHC/peptide complex showed that
Reinherz, E.L., Tan, K., Tang, L., Kern, P., Liu, J., Xiong, Y., Hussey,
both peptide and MHC residues were contacted by TCR R.E., Smolyar, A., Hare, B., Zhang, R., et al. (1999). Science 286,
and that the binding mode was like that of other TCR/ 1913–1921.
peptide/MHC complexes (Reiser et al., 2000). The struc- Reiser, J.-B., Darnault, C., Guimezanes, A., Gregoire, C., Mosser,
ture of this allo-complex adds evidence to the latter T., Schmitt-Verhulst, A.-M., Fontecilla-Camps, J.C., Malissen, B.,
proposal, namely, that allo-recognition is very similar Housset, D., and Mazza, G. (2000). Nat. Immunol. 1, 291–297.
to other TCR reactions, but there are just more novel Sloan-Lancaster, J., and Allen, P.M. (1996). Annu. Rev. Immunol.
14, 1–27.complexes generated by peptide/allo-MHC interac-
tions. Hypothetical molecular models constructed of Speir, J.A., Garcia, K.C., Brunmark, A., Degano, M., Peterson, P.A.,
Teyton, L., and Wilson, I.A. (1998). Immunity 8, 553–562.other allo-complexes suggest the same conclusion
(Speir et al., 1998; Reinherz et al., 1999). Teng, M.K., Smolyar, A., Tse, A.G., Liu, J.H., Liu, J., Hussey, R.E.,
Nathenson, S.G., Chang, H.C., Reinherz, E.L., and Wang, J.H. (1998).The X-ray structure of the murine allo-complex had
Curr. Biol. 8, 409–412.an unusually positioned CDR3a loop (green in Figure
2D) that is folded back away from the peptide and only
in contact with one MHC residue (arrow in Figure 2D).
As a result of the unusual position of the CDR3 loop
there are fewer TCR/peptide contacts in this complex,
rendering this particular TCR/MHC interaction less pep-
tide sequence–dependent (Reiser et al., 2000). The inter-
face also contains a large cavity estimated to contain
30 solvent molecules.
Summary
X-ray crystal structures of abTCRs bound to MHCI and
MHCII molecules with bound antigenic peptides reveals
the atomic contacts upon which MHC restricted T cell
recognition is based. Very different signals can result
from very similar structures and identical signals can
result from different structures (Figures 2C and 2D). An
important caveat is that the CD3 and zeta chains of
the TCRs and all of the transmembrane anchors and
cytoplasmic segments were absent from all of the crys-
